WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2003053402) ZERO-ORDER SUSTAINED RELEASED DOSAGE FORMS AND METHOD OF MAKING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2003/053402    International Application No.:    PCT/US2002/041104
Publication Date: 03.07.2003 International Filing Date: 19.12.2002
Chapter 2 Demand Filed:    10.07.2003    
IPC:
A61K 9/20 (2006.01), A61K 9/28 (2006.01)
Applicants: PHARMACIA CORPORATION [US/US]; Corporate Patent Department, 800 N. Lingbergh Blvd-04E, St. Louis, MO 63167 (US) (For All Designated States Except US).
HEIMLICH, John, M. [US/US]; (US) (For US Only).
NOACK, Robert, M. [US/US]; (US) (For US Only).
COX, Steve, R. [US/US]; (US) (For US Only).
GANORKAR, Loksidh, D. [MU/US]; (US) (For US Only).
VERHAGE, Ronald, R. [US/US]; (US) (For US Only).
JOHN, Lee, E. [US/US]; (US) (For US Only)
Inventors: HEIMLICH, John, M.; (US).
NOACK, Robert, M.; (US).
COX, Steve, R.; (US).
GANORKAR, Loksidh, D.; (US).
VERHAGE, Ronald, R.; (US).
JOHN, Lee, E.; (US)
Agent: KING, Karen, B.; Pharmacia Corporation, 800 N. Lindbergh Boulevard - 04E, St. Louis, MO 63167 (US)
Priority Data:
60/342,819 20.12.2001 US
60/342,642 20.12.2001 US
Title (EN) ZERO-ORDER SUSTAINED RELEASED DOSAGE FORMS AND METHOD OF MAKING THE SAME
(FR) FORMES DOSIFIEES A LIBERATION SOUTENUE D'ORDRE ZERO ET PROCEDE DE PRODUCTION ASSOCIE
Abstract: front page image
(EN)The present invention relates to zero-order sustained release solid dosage forms suitable for administration of a wide range of therapeutically active medicaments, especially those that are water-soluble, and to a process of making same. The solid dosage form comprises (a) a matrix core comprising ethylcellulose and the active agent and (b) a hydrophobic polymer coating encasing the entire matrix core.
(FR)L'invention concerne des formes dosifiées solides à libération soutenue d'ordre zéro appropriées à l'administration d'une large gamme de médicaments thérapeutiquement actifs, en particulier ceux solubles dans l'eau; ainsi qu'un procédé de production associé. La forme dosifiée solide comprend (a) un noyau matriciel contenant de l'éthylcellulose et un principe actif, et (b) un enrobage polymère hydrophobe renfermant la totalité du noyau matriciel.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)